About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,001 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,001 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 13,001 trials

CompletedBOTOX® Open-Label Treatment in Pediatric Upper Limb SpasticityThis study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.NCT01603615·Pasadena, California and 47 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

TerminatedA Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.NCT06685835·Phoenix, Arizona and 71 others

CompletedEvaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionEMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with…NCT01812447·Fort Smith, Arkansas and 33 others

Active not recruitingPhase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC)…NCT05624749·Anniston, Alabama and 89 others

CompletedMOMENTUM 3 IDE Clinical Study ProtocolThe objective of the study is to evaluate the safety and effectiveness of the HM3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of…NCT02224755·Little Rock, Arkansas and 68 others

TerminatedA Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)This is an open-label, multi-center, international, Phase 1/2 study to assess the safety, PK and efficacy of CC-92480 monotherapy and in combination with dexamethasone in subjects…NCT03374085·Duarte, California and 53 others

RecruitingTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerThe purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to…NCT02693535·Birmingham, Alabama and 180 others

CompletedBone Marrow Transplant With Abatacept for Non-Malignant DiseasesThis is a single arm, phase I study to assess the tolerability of abatacept when combined with cyclosporine and mycophenolate mofetil as graft versus host disease prophylaxis in…NCT01917708·Atlanta, Georgia

CompletedPharmacogenomic Evaluation of Antihypertensive Responses 2There are many medications available for the treatment of high blood pressure (hypertension), but finding the right one for a specific patient can be challenging.NCT01203852·Gainesville, Florida and 2 others

Active not recruitingEvaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic AneurysmsProspective, non-randomized, , multicenter study with two independent arms: * Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System.NCT03728985·Birmingham, Alabama and 43 others

CompletedPredicting Response to Standardized Pediatric Colitis TherapyThis is a multi-center, open-label study to determine the safety and effectiveness (how well it works) of two standardized treatments called "mesalamine" (Pentasa®) and…NCT01536535·Los Angeles, California and 28 others

RecruitingSafety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureThis study will compare two different methods to pace the heart to treat heart failure including: 1.NCT07069738·Huntsville, Alabama and 39 others

CompletedThe Dual Antiplatelet Therapy Study (DAPT Study)The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second…NCT00977938·Fairhope, Alabama and 255 others

CompletedSafety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and CirrhosisThe primary objective of this study is to evaluate the efficacy, safety, and tolerability of treatment with sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) fixed-dose…NCT02639338·Long Beach, California and 69 others

CompletedEfficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensThis study will assess the safety and efficacy of two different doses and two different dose regimens of subcutaneous secukinumab in patients that have moderate to severe…NCT01406938·Fresno, California and 130 others

TerminatedZephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligrams (mg)/kilogram (kg) intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to…NCT04419558·Birmingham, Alabama and 156 others

CompletedSafety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2Study of the safety and immunogenicity of 20vPnC and a booster dose of BNT162b2 administered at the same visit or each vaccine given aloneNCT04887948·Anaheim, California and 26 others

CompletedMonoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With NeuroblastomaThis phase III trial is studying the side effects of giving monoclonal antibody Ch14.18 together with sargramostim, aldesleukin, and isotretinoin after autologous stem cell…NCT01041638·Loma Linda, California and 31 others

CompletedHCV-TARGET- Hepatitis C Therapeutic Registry and Research NetworkThe primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both…NCT01474811·Phoenix, Arizona and 59 others

TerminatedStudy to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)The purpose of this study is to evaluate the safety and efficacy of avelumab when combined with either crizotinib or PF-06463922.NCT02584634·Atlanta, Georgia and 19 others

PreviousPage 26 of 651Next

in Atlanta

Heart Diseasein Atlanta